bendamustine hydrochloride has been researched along with Radiodermatitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, R; Amagai, M; Funakoshi, T; Kikuchi, T; Koda, Y; Kurihara, Y; Mori, T; Okamoto, S; Sato, H; Shimizu, T; Tsunoda, K; Yamagami, J | 1 |
1 other study(ies) available for bendamustine hydrochloride and Radiodermatitis
Article | Year |
---|---|
Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Autoimmunity; Bendamustine Hydrochloride; Combined Modality Therapy; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunologic Factors; Lymphoma, Follicular; Neoplasm Grading; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Pemphigus; Radiodermatitis; Rituximab; Severity of Illness Index; Skin; Treatment Outcome; Tumor Burden | 2017 |